238 related articles for article (PubMed ID: 2030816)
1. Chemotherapy in non-Hodgkin's lymphoma during pregnancy.
Lambert J; Wijermans PW; Dekker GA; Ossenkoppele GJ
Neth J Med; 1991 Feb; 38(1-2):80-5. PubMed ID: 2030816
[TBL] [Abstract][Full Text] [Related]
2. [Disseminated, highly malignant non-Hodgkin's lymphoma and pregnancy: polychemotherapy in the 2d and 3d trimester].
du Bois A; Runge M; Schmid J; Hillemanns HG
Geburtshilfe Frauenheilkd; 1990 May; 50(5):405-9. PubMed ID: 2373337
[TBL] [Abstract][Full Text] [Related]
3. Aggressive primary thyroid non Hodgkin's lymphoma with pregnancy.
Soliman KB; Abbas MM; Seksaka MA; Wafa S; Balah AS
Saudi Med J; 2007 Apr; 28(4):634-6. PubMed ID: 17457494
[TBL] [Abstract][Full Text] [Related]
4. Multi-agent chemotherapy in a case of non-Hodgkin's lymphoma in second trimester of pregnancy.
Moore DT; Taslimi MM
J Tenn Med Assoc; 1991 Sep; 84(9):435-6. PubMed ID: 1921384
[No Abstract] [Full Text] [Related]
5. Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy.
Nantel S; Parboosingh J; Poon MC
Med Pediatr Oncol; 1990; 18(2):143-5. PubMed ID: 1689451
[TBL] [Abstract][Full Text] [Related]
6. [Primary cervical epidural low-grade non-hodgkin's lymphoma: a case report and review of the literature].
Lahiani Ben Salah H; Daoud J
Cancer Radiother; 2008 Dec; 12(8):863-6. PubMed ID: 18565781
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child.
Sagan D; Semczuk A; Lampka E
J Obstet Gynaecol Res; 2010 Aug; 36(4):882-6. PubMed ID: 20666963
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy for non-Hodgkin's lymphoma].
Kuraishi Y; Usui N; Dobashi N
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2210-6. PubMed ID: 9881077
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Kosmas C; Malamos NA; Antonopoulos MJ
N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841319
[No Abstract] [Full Text] [Related]
12. Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma.
Ohnoshi T; Hayashi K; Mizuta J; Tagawa S; Matsutomo S; Saito S; Kawashima K; Akagi T; Kimura I
Int J Hematol; 1993 Jan; 57(1):61-6. PubMed ID: 7682860
[TBL] [Abstract][Full Text] [Related]
13. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
14. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Machida U; Kami M; Hirai H
N Engl J Med; 1998 Nov; 339(20):1475-6; author reply 1477. PubMed ID: 9841318
[No Abstract] [Full Text] [Related]
15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
17. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V
Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723
[TBL] [Abstract][Full Text] [Related]
18. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
19. Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma.
Mounier N; Gisselbrecht C; Lepage E
N Engl J Med; 1998 Nov; 339(20):1476; author reply 1477. PubMed ID: 9841320
[No Abstract] [Full Text] [Related]
20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
